Does an asymmetric lobe in digital rectal examination include any risk for prostate cancer? results of 1495 biopsies.
Yilmaz, Ömer; Kurul, Özgür; Ates, Ferhat; Soydan, Hasan; Aktas, Zeki.
Int Braz J Urol
; 42(4): 704-9, 2016 Jul-Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27564280
Evaluation of PCA3 and multiparametric MRI's: collective benefits before deciding initial prostate biopsy for patients with PSA level between 3-10ng/mL.
Prostate cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer.
Predictive role of Trimprob associated with multiparametric MRI in the diagnosis of prostate cancer.
High cancer detection rate using cognitive fusion - targeted transperineal prostate biopsies.
Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
Can MRI/TRUS fusion targeted biopsy replace saturation prostate biopsy in the re-evaluation of men in active surveillance?
Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer.
Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients.
Prostate-specific antigen testing in men between 40 and 70 years in Brazil: database from a check-up program.